Literature DB >> 33838343

A brief history of carbon monoxide and its therapeutic origins.

Christopher P Hopper1, Paige N Zambrana2, Ulrich Goebel3, Jakob Wollborn4.   

Abstract

It is estimated that 10% of carbon throughout the cosmos is in the form of carbon monoxide (CO). Earth's earliest prebiotic atmosphere included the trinity of gasotransmitters CO, nitric oxide (NO), and hydrogen sulfide (H2S), for which all of life has co-evolved with. The history of CO can be loosely traced to mythological and prehistoric origins with rudimentary understanding emerging in the middle ages. Ancient literature is focused on CO's deadly toxicity which is understandable in the context of our primitive relationship with coal and fire. Scientific inquiry into CO appears to have emerged throughout the 1700s followed by chemical and toxicological profiling throughout the 1800s. Despite CO's ghastly reputation, several of the 18th and 19th century scientists suggested a therapeutic application of CO. Since 2000, the fundamental understanding of CO as a deadly nuisance has undergone a paradigm shift such that CO is now recognized as a neurotransmitter and viable pharmaceutical candidate. This review is intended to provide a brief history on the trace origins pertaining to endogenous formation and therapeutic application of CO.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CORM; Carbon monoxide; Carbonic oxide; Carboxyhemoglobin; Gasotransmitters; Heme oxygenase; History; Poisoning

Year:  2021        PMID: 33838343     DOI: 10.1016/j.niox.2021.04.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  3 in total

1.  Flavonol-Based Carbon Monoxide Delivery Molecule with Endoplasmic Reticulum, Mitochondria, And Lysosome Localization.

Authors:  Livia S Lazarus; C Taylor Dederich; Stephen N Anderson; Abby D Benninghoff; Lisa M Berreau
Journal:  ACS Med Chem Lett       Date:  2022-02-01       Impact factor: 4.632

Review 2.  Gases in Sepsis: Novel Mediators and Therapeutic Targets.

Authors:  Zhixing Zhu; Stephen Chambers; Yiming Zeng; Madhav Bhatia
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

3.  Correction: Improving on estimates of the potential relative harm to health from using modern ENDS (vaping) compared to tobacco smoking.

Authors:  Nick Wilson; Jennifer A Summers; Driss Ait Ouakrim; Janet Hoek; Richard Edwards; Tony Blakely
Journal:  BMC Public Health       Date:  2022-09-21       Impact factor: 4.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.